Prepared by FDA-registered, state-board-regulated pharmacies following USP sterility and potency standards
The Wolverine Stack combines BPC-157 with TB-500, a second peptide that supports cell migration and systemic tissue regeneration
GHK-Cu FDA Approval Status 2026: Injectable Rules Overview GHK-Cu FDA Approval Status 2026: Injectable Rules
Chemical Composition Representative component structure of individual component peptides blend contains four distinct peptides (Source: PubChem) Technical Specifications The blend combines four distinct peptide classes : a gastric-derived pentadecapeptide (BPC-157), an actin-sequestering peptide (TB-500), a copper-binding tripeptide (GHK-Cu), and an anti-inflammatory tripeptide (KPV), creating a comprehensive research tool that addresses tissue regeneration, cellular migration, matrix remodeling, and inflammation control simultaneously
Wound and Tissue Remodeling Studies Published GHK-Cu research includes multiple studies in wound healing models
See our peptide stacking research guide for guidance on experimental design with multiple compounds